Shortening Treatment by Advancing Novel Drugs

Clinical trial NCT02342886 · COMPLETED

Trial details

NCT number: NCT02342886
Sponsor: Global Alliance for TB Drug Development
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tuberculosis, Pulmonary, Drug Sensitive Tuberculosis, Pulmonary, Multi Drug-resistant

Start date: 2015-02-01
Primary completion: 2018-01-01
Enrollment: 284

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.